Skip to content

AARD AARD Total Liabilities

Total Liabilities at other companies

Relmada Therapeutics, Inc. logo
Relmada Therapeutics, Inc.RLMD
$16.63M+217%
Rhythm Pharmaceuticals, Inc. logo
Rhythm Pharmaceuticals, Inc.RYTM
$204.7M-8.5%
Aquestive Therapeutics, Inc. logo
Aquestive Therapeutics, Inc.AQST
$175.18M+7.4%
Viking Therapeutics logo
Viking TherapeuticsVKTX
$106.33M+430%
Arvinas logo
ArvinasARVN
$260.7M-23.5%
Protagonist Therapeutics logo
Protagonist TherapeuticsPTGX
$41.99M-20.9%

Other financials

Income statement

See full
Revenue-
Operating income-$22.5M-115%
Net income-$21.6M-132%
EPS (diluted)-$0.99-39.4%

Balance sheet

See full
Cash & equivalents$62.4M+136%
Total debt$336.0K-53.7%
Total equity$87.0M-42.3%
Total assets$98.6M-37.2%

Cash flow

See full
Operating cash flow-$18.9M-65.7%
CapEx--100%
Free cash flow-$16.8M-117%

Valuation

See full
Market cap$124.35M-58.6%
Enterprise value$62.25M-77.4%

Returns & leverage

See full
Return on equity-58.8%
Debt / equity0.0×
Current ratio8.1×-17.8×

Where this comes from

Reported directly by AARD in its filing.

Tagged under the XBRL concept us-gaap:Liabilities.

The official record: AARD’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about AARD's total liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is AARD's total liabilities?
AARD (AARD) reported total liabilities of $11.6M in Q1 2026.
How has AARD's total liabilities changed year-over-year?
AARD's total liabilities increased by 83.1% year-over-year, from $6.34M to $11.6M.
What does total liabilities mean?
The sum of all current and non-current obligations — everything the company owes to creditors, employees, governments, and other stakeholders.